Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial

scientific article

Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/EUROPACE/EUU217
P698PubMed publication ID25210025
P5875ResearchGate publication ID265557679

P50authorEugene BraunwaldQ322114
Sabina A MurphyQ114308442
Samuel C VoloQ114358681
Benjamin M SciricaQ114427115
Ewa Karwatowska-ProkopczukQ125171876
P2093author name stringDavid A Morrow
Luiz Belardinelli
Bernard R Chaitman
Jonathan W Waks
Mei L Cheng
P2860cites workESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)Q22242892
Mechanisms of ranolazine's dual protection against atrial and ventricular fibrillationQ26995558
Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic propertiesQ34339876
Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trialQ34578958
Atrial fibrillation and death after myocardial infarction: a community studyQ35125950
Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditionsQ36485492
Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazineQ36507053
Role of late sodium channel current block in the management of atrial fibrillationQ36570112
Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trialQ37394525
Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazineQ43196284
Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevationQ44480000
Antiarrhythmic effects of ranolazine in a guinea pig in vitro model of long-QT syndromeQ44805574
Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial InQ46048410
Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heartQ46082698
An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytesQ46725746
Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac deathQ50157358
P433issue1
P921main subjectacute coronary syndromeQ266018
Atrial FibrillationQ815819
P304page(s)32-37
P577publication date2014-09-10
P1433published inEP EuropaceQ2596718
P1476titleEffect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial
P478volume17

Reverse relations

cites work (P2860)
Q38770111A Review of the Relationship of Atrial Fibrillation and Acute Coronary Syndrome
Q38853630Antiarrhythmic Drug Therapy for Rhythm Control in Atrial Fibrillation
Q38297786Antiarrhythmic therapy in 2014: Contemporary approaches to treating arrhythmias
Q26778659Atrial fibrillation in patients with diabetes: molecular mechanisms and therapeutic perspectives
Q47713126Ca2+/calmodulin-dependent kinase II-dependent regulation of atrial myocyte late Na+ current, Ca2+ cycling, and excitability: a mathematical modeling study
Q38813373Inhibition of Late Sodium Current as an Innovative Antiarrhythmic Strategy
Q36877207Low Homoarginine Levels in the Prognosis of Patients With Acute Chest Pain
Q38985149Novel Use of Ranolazine as an Antiarrhythmic Agent in Atrial Fibrillation
Q38969897Ranolazine Added to Amiodarone Facilitates Earlier Conversion of Atrial Fibrillation Compared to Amiodarone-Only Therapy.
Q38420631Ranolazine for the treatment of atrial fibrillation
Q26784029Ranolazine in Cardiac Arrhythmia
Q39274533Ranolazine reduces atrial fibrillatory wave frequency
Q55080711Ranolazine: A true pluripotent cardiovascular drug or jack of all trades, master of none?
Q86038219Short-course of ranolazine prevents postoperative atrial fibrillation following coronary artery bypass grafting and valve surgeries
Q38821307The Significance of the Late Na+ Current for Arrhythmia Induction and the Therapeutic Antiarrhythmic Potential of Ranolazine
Q48746789The combined effects of ranolazine and dronedarone on human atrial and ventricular electrophysiology

Search more.